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Background: Excess adipose tissue and sarcopenia presents a multifaceted clinical challenge that promotes
morbidity and mortality in the obese, elderly population. Unfortunately, the mortality risks of muscle loss may
outweigh the potential benefits of weight loss in the elderly. We have previously demonstrated the effectiveness of
whey protein and essential amino acids towards the preservation of lean tissue, even under the conditions of strict
bedrest in the elderly.
Methods: In the context of caloric restriction-based weight loss, we hypothesized that a similar formulation given
as a meal replacement (EAAMR) would foster the retention of lean tissue through an increase in the skeletal muscle
fractional synthesis rate (FSR). We also proposed that EAAMR would promote the preferential loss of adipose tissue
through the increased energy cost of skeletal muscle FSR. We recruited and randomized 12 elderly individuals to an
8 week, caloric restriction diet utilizing equivalent caloric meal replacements (800 kcal/day): 1) EAAMR or a 2)
competitive meal replacement (CMR) in conjunction with 400 kcal of solid food that totaled 1200 kcal/day
designed to induce 7% weight loss. Combined with weekly measurements of total body weight and body
composition, we also measured the acute change in the skeletal muscle FSR to EAAMR and CMR.
Results: By design, both groups lost ~7% of total body weight. While EAAMR did not promote a significant
preservation of lean tissue, the reduction in adipose tissue was greater in EAAMR compared to CMR. Interestingly,
these results corresponded to an increase in the acute skeletal muscle protein FSR.
Conclusion: The provision of EAAMR during caloric restriction-induced weight loss promotes the preferential
reduction of adipose tissue and the modest loss of lean tissue in the elderly population.
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The elderly population is particularly prone to the acce-
lerated loss of muscle mass or sarcopenia with advancing
age. Sarcopenia is complicated by the combined influence
of physical inactivity and poor nutrition that often accom-
panies the aging process [1]. The condition of sarcopenia
is inextricably linked to loss of functional capacity, and
increased risk of morbidity and mortality [2-5]. While the
precise etiology of sarcopenia has yet to elucidated, recent
evidence points to a overall reduction in the anabolic
response of skeletal muscle to the consumption of mixed
macronutrient intake [6,7], potentially contributing to
chronic, progressive reduction of muscle mass with advan-
cing age.
Combined with the challenge of sarcopenia, the preva-
lence of obesity among elderly adults has increased
dramatically [8]. The concomitant development of sarco-
penic obesity results in the formation of overlapping
health problems that combine the negative influences of
inflammation, frailty and metabolic syndrome [9,10].
Moreover, caloric restriction-induced weight loss that is
often utilized to dampen the negative consequences of
metabolic syndrome may be considered counterpro-
ductive when measured against weight loss-induced acce-
leration of sarcopenia [11].
While moderate increases in dietary protein intake
beyond the Recommended Daily Allowance (RDA) have
been suggested to enhance anabolic activity in skeletal
muscle [12], amino acid consumption have also been
shown to facilitate an increase in muscle protein synthesis
[13,14]. In addition, supplementation of high quality
protein twice a day promoted an increase in lean body
mass, strength and functional capacity in elderly volunteers
with concomitant changes in diet or activity [15]. The
development of the most potent formulation of whey
protein and amino acid supplementation would potentially
protect against the negative consequences of sarcopenic
obesity in the elderly.
To meet our aims, we chose a caloric restriction para-
digm designed to elicit 7% weight loss and decrease meta-
bolic risk [15]. Our overriding hypothesis was that the
supplementation of our whey protein + essential amino acid
meal replacement (EAAMR) formulation will be required
to promote the optimal reduction of adipose tissue while
preserving lean tissue in obese, elderly adults. We also
proposed that the changes in body composition would
occur in conjunction with an increase in the skeletal muscle
protein fractional synthetic rate (FSR) to EAAMR
compared to competitive meal replacement (CMR).
Methods
Recruitment and screening
We recruited and enrolled healthy males and females,
ages = 65-80 years of age and of all races and ethnicbackgrounds for a caloric restriction-based weight loss
intervention designed to promote 7% weight loss. All
volunteers were weight stable and were not participating
in a weight loss or exercise program at the time of
enrollment. Volunteers refrained from alcohol consump-
tion (24 h) and intense physical activities (72 h) prior to
pre- and post-weight loss study visits. Volunteers also
reported in the fasted state beginning at 20:00 h the day
prior to pre- and post-weight loss study visits.
In conjunction with the consumption of solid food in
both groups, subjects were randomized to one of two
groups that would consume either EAAMR or a CMR
five times/day. Volunteers were recruited through the
conspicuous placement of IRB-approved flyer throughout
the community, and completed a telephone screening.
Potential subjects were then asked to report for a visit to
our clinic, where they were then consented.
We excluded any patient with a chronic inflammatory
condition or malignancy. We also excluded any individual
who could not discontinue the use of aspirin or other
anti-coagulant medication. In addition, volunteers with a
history of diabetes, cardiovascular disease or recent history
of cancer (within 3 years) were also excluded. We also
excluded any individual whose body weight had changed
more than 10 pounds in the previous 3 months. Due to
the nature of the weight loss intervention, we excluded all
volunteer with allergies to milk products.
It would have been impractical to exclude all patients
taking medications, and we could not ethically discon-
tinue all medications for the duration of the intervention.
As a result, we permitted the concomitant use of HMG
CoA-reductase inhibitors, thiazide diuretics, beta-1 selec-
tive blockers, clonidine, antidepressant selective serotonin
reuptake inhibitors, and estrogen replacement/oral
contraceptives.
Weight loss study design
All medical screenings included a baseline blood sample
collection for a lipid and metabolic panel. Based on eligi-
bility, volunteers were randomly assigned to one of two
groups: 1) 7% weight loss with EAAMR, or 7% weight
loss using CMR. Both groups consumed 5 servings of a
meal replacement (170 kcal x 5 servings/day) and
~400 kcal/day of solid food that yielded ~1250 kcal/day.
Regardless of group assignment, the total kcal/week
remained constant throughout the intervention to
ensure a high level of compliance and allow for consis-
tent, reliable reductions in the amount of weight lost.
Obese, elderly volunteers in both groups (EAAMR or
CMR) completed one visits that included a stable iso-
tope experimental session described below. Following
the completion of the experimental testing sessions, all
volunteers were instructed to consume a low calorie diet
for 8 weeks. During this weight loss intervention,
Coker et al. Nutrition Journal 2012, 11:105 Page 3 of 7
http://www.nutritionj.com/content/11/1/105volunteers consumed ~1250 kcal/day consisting of solid
food and liquid supplements. Although the time course
of the caloric restriction phase may seem somewhat
overbearing from a logistical standpoint, the difficulty
entailed was dramatically reduced through the use of
pre-packaged meal replacements either in the form of
EAAMR or CMR that required no preparation. In
addition, we suggested solid food products preferred by
clients in the UAMS weight loss clinic that achieve opti-
mal compliance and consistently provide predictable
weight loss. Body weight and body composition was
measured weekly by our clinical staff. Any volunteer that
failed to lose weight on two subsequent visits was
removed from the study for noncompliance to the
protocol.
Experimental Paradigm. Prior to initiation of the weight
loss intervention, volunteers in both groups completed a
testing session designed to examine the influence of
EAAMR and CMR on skeletal muscle protein FSR.
Subjects were instructed to fast after 2200 hrs, with water
permitted. On the day of the testing session, subjects
reported to the study site, and two intravenous catheters
were inserted by our registered nurse. One catheter was
utilized for the infusion of stable isotopes, while the other
was utilized for blood sampling. A primed (2 μmol/kg),
constant (0.07 μmol/kg/min) infusion of ring- [13]
C6-phenylalanine began after obtaining a background blood
sample and the isotopic infusion was maintained for 6
hours. Blood was sampled at 20 min intervals to determine
tracer enrichment and blood amino acid levels. A tissue
biopsy of the vastus lateralis muscle was taken under local
anesthesia at t = 60, 180 and 240 min [16]. Biopsies were
utilized for the determination of skeletal muscle protein
FSR by tracer methodology [17]. After the initial biopsy at
t = 60 min, subjects were provided with a single dose of
EAAMR or CMR. At t = 180 and t = 240 min, two biopsies
were taken to evaluate the influence of EAAMR or CMR
on the incorporation of the phenyalalnine tracer into the
muscle.
We have previously demonstrated that characterization
of this acute response to EAA reflects the 24 h response,
and that skeletal muscle protein FSR remains constant for
the entire 8 hours if no drink is given [18]. While both pro-
ducts were presented in a tetrapak, and in a palatability for-
mat that precluded specific determination of either product
by the volunteer, the knowledge of the product alone would
not have influenced skeletal muscle protein FSR. Following
the completion of the infusion protocol and biopsy, cathe-
ters were withdrawn, the biopsy site was dressed, and after
consult with the study physician, the subject was released.
Body weight and composition
We measured body mass, BMI, and body composition
pre- and post-weight loss, and during each weekly visit.Total body mass was to the nearest 0.1 kg using an
electronic scale (Ohaus Corp, USA). A GAIA 359 PLUS
(Kyungsang Buk-do, KOREA) unit measured fat mass,
lean tissue mass, soft lean mass and percent body fat




The isotopic enrichment of L-[ring- [13]C6]phenylalanine
in blood was determined on an HP Model 5973 GCMS
(Hewlett-Packard Co., Palo Alto, CA) by electron impact
ionization and selected ion monitoring [17].
Muscle
Tissue biopsies of the vastus lateralis were immediately
rinsed with cold saline, blotted, and frozen in liquid ni-
trogen. These tissue samples were stored at -80°C until
processed. The TBDMS derivative was prepared for the
intracellular free water as previously described 56, and
analyzed by gas chromatography/mass spectrometry
(GCMS) (Model 5973) using electron impact ionization.
The protein-bound enrichment of phenylalanine was
analyzed as previously described by GCMS [17].
Calculation of skeletal muscle protein FSR
Skeletal muscle protein FSR was calculated from the
determination of the rate of tracer incorporation into
the protein and the enrichment of the intracellular pool
as the precursor:





where Ep1 and Ep2 are the enrichments of the protein-
bound L-[ring- [13]C6]phenylalanine at t = 60, 180, and 240
min. EM represented the average intracellular L-[ring- [13]
C6]phenylalanine enrichments over the time of incorpo-
ration; and t is the time in minutes. The factors 60 and 100
were required to express skeletal muscle protein FSR in
percent per hour. Skeletal muscle protein FSR was calcu-
lated from the biopsies at 60 and 180 min to determine
fasting protein synthetic rate, and also from t = 180 min
and t = 240 min to determine the effect of drink administra-
tion. The drink was given immediately after the 180 min
biopsy and thus incorporation of the tracer from 180-240
min reflects acute nutritional response. From the skeletal
muscle protein FSR and lean body mass determination the
total change in skeletal muscle protein synthesis was
estimated [18].
Statistical analysis
Variables were summarized using means, standard devia-
tions, medians and ranges. The groups were compared
with respect to changes in adipose and lean tissue, and
Table 2 Plasma glucose and lipid variables
EAAMR CMR
Glucose (mg/dl) 97 ± 4 103 ± 7
Triglycerides (mg/dl) 154 ± 22 115 ± 13
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muscle protein FSR, using Student two-sample t-tests.
An alpha-level of 5% was used to determine statistical
significance.Total cholesterol (mg/dl) 168 ± 7 191 ± 9
High density lipoprotein (mg/dl) 47 ± 4 47 ± 5
Very low density lipoprotein 31 ± 4 23 ± 3
Low density lipoprotein (mg/dl) 86 ± 9 121 ± 12
Values are means ± SEM. There were no significant differences in these
baseline variables (P > 0.05).Results
Subjects
We enrolled 12 volunteers, and one subject dropped out
due to their inability to comply with the protocol.
Therefore, 11 obese women and men lost 7% of total
body weight, and completed all aspects of the study.
There were no baseline differences in age, BMI or
percent fat, or the distribution of gender equity between
the EAAMR and CMR groups (p > 0.05) (Table 1). Of
these individuals, one of the individuals in the EAAMR
group had undergone a hip replacement in 2003, and
one of the individuals in the CMR group had been suc-
cessfully treated for cancer in 1999. In addition, four out
of the 11 individuals were taking simvastatin or nexium,
and two of the 11 individuals were taking estradiol.
Baseline Metabolic and Lipid Parameters. There were
no significant differences in the fasting glucose values
between EAAMR and CMR (p > 0.05) (Table 2). In
addition, there were no differences in triglycerides, total
cholesterol, high density lipoprotein or very low density
lipoprotein (p > 0.05). While there was a trend towards
reduced low density lipoprotein in EAAMR, it was not
significant (p = 0.10).Anthropometrics
Relative to the caloric restriction-induced weight loss
interventions, there was a significant and similar 7%
reduction in body weight in EAAMR and CMR (Table 1).
While there was no difference in absolute amount of
weight loss, EAAMR promoted a greater reduction in
adipose tissue compared to CMR (p < 0.05) (Table 1)
(Figure 1). The consumption of the EAAMR also
seemed to foster greater preservation of lean tissue
compared to CMR. However, the difference between
EAAMR and CMR was not significant (p = 0.26)
(Figure 2).Table 1 Age and Anthropometrics (pre- and post-
intervention
EAAMR CMR
Pre WL Post WL Pre WL Post WL
Age 70 ± 2 68 ± 2
Body weight (kg) 92.3 ± 3.9 84.5 ± 3.3* 91.4 ± 2.4 84.6 ± 2.4
Body mass index (kg/m2) 31.3 ± 0.5 29.1 ± 0.7 31.3 ± 0.5 30.0 ± 0.4
Percent Fat 41.8 ± 1.1 36.3 ± 1.1* 38.9 ± 1.5 37.5 ± 0.2
Values are means ± SEM. There were no significant differences in these
variables at basekine. *Denotes a significant change from pre-to post-
intervention (P < 0.05).Plasma and muscle phenyalanine enrichments
Basal plasma phenyalanine enrichments were not different
between EAAMR and CMR (p > 0.05). Upon ingestion of
each product, muscle phenyalanine enrichments increased
(p < 0.05) dramatically in EAAMR compared to no change
with CMR (p > 0.05).
Skeletal Muscle Fractional Protein Synthesis. Skeletal
muscle protein FSR increased by 0.0142 ± 0.0154% in
CMR (Figure 3). In contrast, there was a greater increase
(ie., 0.0534 ± 0.0069%) in skeletal muscle protein FSR in
EAAMR (p < 0.05) (Figure 3).
Discussion
Our experimental approach allowed us to determine
whether consumption of EAAMR was more effective
than CMR in promoting the concomitant reduction of
adipose tissue and preservation of lean tissue during
caloric restriction-induced weight loss in elderly, obese
individuals. Due to the relative importance of in vivo
energetics of muscle protein turnover towards energy
expenditure [19], we also evaluated the acute influence of
EAAMR compared to CMR on skeletal muscle proteinFigure 1 Change in adipose tissue in EAAMR and CMR
following weight loss. * Denotes significance difference between
groups.
Figure 2 Change in lean tissue in EAAMR and CMR following
weight loss.
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weight loss paradigm, there was a 30% greater loss of
adipose tissue with EAAMR compared to CMR. While
the sample size may have affected the outcome, con-
sumption of EAAMR seemed to favor the preservation of
lean tissue but was not significant with the limited
number of participants [20]. Nonetheless, skeletal muscle
FSR was significantly higher with the acute consumption
of EAAMR versus CMR, and may have been responsible
for the preferential loss of adipose tissue with EAAMR.
The macronutrients contained in a single serving of
EAAMR and CMR are described in Table 3. It is important
to mention that the total caloric value for a single serving
of EAAMR and CMR was ~170 kcal. The amount/type of
carbohydrate was identical in both formulations. Also, the
total amount of fat was 4 grams in EAAMR and 3 grams in
CMR with the proportion of saturated fat being 1 gram in
both EAAMR and CMR. The primary differences betweenFigure 3 Change in feeding induced skeletal muscle FSR in
EAAMR and CMR following weight loss. * Denotes significance
difference between groups.EAAMR and CMR were the total amount/type of intact
protein and the total amount and formulation of essential
amino acids. While EAAMR contained 7 grams of intact
protein from whey protein, CMR contained 14 grams intact
protein derived from sodium casenate and calcium
casenate. Leucine comprises approximately 40% of the
EAAs, in accord with our research defining the optimal
formulation of EAAs for elderly [13,16,21]. We have also
previously demonstrated greater accrual of muscle protein
with whey protein [22], and we proposed that the combi-
nation of whey protein plus 6 grams of our proprietary
essential amino acid formulation would be the most effec-
tive approach against sarcopenic obesity. The total amount
of essential amino acids derived from intact protein and the
essential amino formulation was 9.7 grams in EAAMR.
The total amount of essential amino acids derived from
intact protein was 3.5 grams in CMR. The description high-
lights the fundamental differences between EAAMR and
CMR and the rationale for the source of intact protein and
importance of the essential amino acids formulation.
There are several factors that should be considered
when comparing the effects of meal replacements on
changes in body composition and the energetics of skeletal
muscle in the context of weight loss. Typically, total
energy expenditure is represented by the sum of resting
energy expenditure, the thermic effect of food, and the
energy related to activity [23]. Given that that the experi-
mental protocol was identical in both groups except for
the nutrient profile of the meal replacements, we can
make the assumption that basal energy expenditure and
activity related energy expenditure were not responsible
for the differences between EAAMR and CMR. Other fac-
tors such as the administration of the meal replacements,
timing sequence of the protocol, the characterization of
the subjects, and the length of the protocol could have
also influenced the results related to body composition.Table 3 Nutrition Facts for EAAMR and CMR
EAAMR CMR
Calories 170 170
Total Fat (grams) 4 3
Saturated Fat (grams) 1 1
Trans Fat (grams) 0 0
Cholesterol (mg) 5 5
Sodium (mg) 220 220
Potassium (mg) 460 460
Total Carbohydrate 22 22
Fiber (grams) 1 1
Sugars (grams) 17 17
Protein (grams) 7 14
Essential amino acid formulation 6 0
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mental design or were not significantly different between
groups. Therefore, the impact of the nutrient profiles
(ie., type of protein and formulation of essential amino
acids) was likely responsible for the greater loss of adipose
tissue through differences in diet-induced energy expend-
iture or the impact of muscle loss sparing on overall en-
ergy expenditure.
While we were not able to achieve statistical signifi-
cance in terms of EAAMR promoting enhanced preser-
vation of lean tissue, the sparing influence of muscle loss
might have been demonstrated with a larger sample size.
This remains an important issue. Acute administration
of EAAMR did promote a significant increase in skeletal
muscle protein FSR compared to CMR. Assuming that
the energy cost of protein synthesis is 3.6 kJ/g and the
baseline GAIA-derived lean tissue mass was 56.4 kg for
EAAMR and 54.4 kg for the CMR, we can extrapolate
that the overall energy discrepancy between the two
groups was roughly equivalent to 27,170 kcal or 3.5 kg
of weight loss across the entire caloric restriction-based
weight loss paradigm. Based on the amount of total lean
mass in each group, this value takes into account a
consistent intervention structure of five servings/day
across an eight week period. In short, these calculations
suggest that differences in the source of intact protein/
formulation of EAA may have a significant influence on
diet induced energy expenditure that coincides closely
with the greater reduction of adipose tissue in EAAMR
compared to CMR.
Despite the greater stimulation of skeletal muscle protein
FSR in EAAMR, these individuals still lost 2.1 ± 0.5 kg of
lean tissue. With an estimated protein intake of 90 grams/
day, this might seem confusing since the recommended
dietary allowance (RDA) of 0.88 kg-1• d-1 would equate to
50 grams of protein in the EAAMR group [24]. On the other
hand, the RDA for protein has been shown to be inadequate
for the maintenance of lean body mass in the elderly popula-
tion [25]. Therefore, the optimal amount of protein intake in
the elderly population remains uncertain [26], especially in
the context of caloric restriction. The underlying reason for
the lack of precise information when it comes to protein in-
take during weight loss in this population may be largely due
to the fact that the protein RDA levels were determined by
studies using nitrogen balance in younger individuals [27]. In
order to attenuate the acceleration of sarcopenia, the amount/
type of protein and/or formulation of essential amino acids
must be elucidated to promote efficacious caloric restriction-
based weight loss in the elderly.
For the effective treatment of sarcopenic obesity, it might
be argued that exercise training should be utilized instead
of or in conjunction with caloric restriction [28]. In fact,
we have also recently demonstrated greater reduction of
adipose tissue through the use of exercise-induced weightloss compared to caloric restriction [29]. There was also a
greater preservation of lean tissue with exercise-induced
weight loss compared to caloric restriction-induced weight
loss [30]. Unfortunately, individuals at risk for metabolic
disease may be limited in their ability to even meet the
guidelines for physical activity much less induce weight
loss through exercise training [30]. In fact, only 30% of
young, healthy Americans currently utilize exercise as an
efficacious strategy for weight loss [31]. These issues are
compounded by the difficulties entailed with maintaining
exercise compliance [32]. Therefore, caloric restriction-
based weight loss provides a potential avenue for an
improvement in metabolic health status and may influence
functional status as well due to the inverse relationship
between obesity and physical activity [33].
Weight loss in the obese, elderly population is typically
contraindicated due to difficult, clinical conundrum of
sarcopenic obesity. While the results of the present
study do not suggest that EAAMR would be sufficient to
completely prevent the reduction of lean tissue during
caloric restriction-induced weight loss, we were able to
demonstrate the preferential reduction of adipose tissue
with 7% weight loss. Moreover, the acute anabolic
response to the ingestion of EAAMR was directly linked
to increased diet-induced caloric expenditure that may
have responsible for the increased loss of adipose tissue.
Due to results of the current investigation, we anticipate
that improvements in insulin sensitivity derived from
the preferential loss of adipose tissue will maximize the
anabolic efficiency to nutrition. Based on earlier studies
where we have examined the influence of EAA on
muscle protein synthesis [21], a two-sample t-test would
have 80% power to detect effect sizes as small as 0.566
in 35 volunteers. It is also important to mention that the
individuals in the current study were still deficient in
terms of the their total protein intake in the context of
caloric restriction, and we are currently revising our
formulation to address this issue. In conclusion, we
propose that high quality protein + essential amino acids
represent a critical variable in the preservation of lean
tissue and augmentation of adipose tissue reduction in
the elderly population.
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